EXECUTIVE BOARD 139th session
EB139/DIV./2 10 June 2016
Decisions and list of resolutions I. DECISIONS EB139(1) Dementia
The Executive Board, having considered the report by the Secretariat on dementia,1 (1) noted that the response to the global burden of dementia can be greatly enhanced by a shared commitment among Member States and all other stakeholders to put in place the necessary policies and resources for care of people with dementia, to promote research, to find disease-modifying treatments or cure, and to give adequate priority to action against dementia in national and global political agendas; (2) decided to request the Director-General to develop with the full participation of Member States and in cooperation with other relevant stakeholders a draft global action plan on the public health response to dementia, with clear goals and targets, for consideration by the Seventieth World Health Assembly, through the Executive Board at its 140th session. (First meeting, 30 May 2016)
EB139(2)
Standing Committee on Nongovernmental Organizations
In accordance with the adoption by the Sixty-ninth World Health Assembly of the Framework of Engagement with Non-State Actors, the Executive Board, through the Programme Budget and Administration Committee, will henceforth conduct the review of any non-State actors applying to be in official relations, as well as the review of renewals. (Third meeting, 31 May 2016)
EB139(3)
Membership of the Programme, Budget and Administration Committee
The Executive Board appointed as members of the Programme, Budget and Administration Committee Dr Nelson Antonio Rodríguez Monegro (Dominican Republic), Dr Lyonpo Tandin Wangchuk (Bhutan), Ms Olivia Wigzell (Sweden), Ms Zhang Yang (China), Dr Ali Hyasat (Jordan) and Dr Stewart Jessamine (New Zealand) for a two-year period or until expiry of their membership on the Board, whichever is first, in addition to Dr Mukengeshayi Kupa (Democratic Republic of the Congo), Mr Omar Sey (Gambia), Dr Thomas Frieden (United States of America), 1
Document EB139/3.
EB139/DIV./2
Dr Phusit Prakongsai (Thailand), Professor Benoît Vallet (France), and Dr Ali Saad Al-Obaidi (Kuwait), who were already members of the Committee. Dr Raymond Busuttil (Malta), Chairman of the Board, and Ms Faeqa Saeed Alsaleh (Bahrain), Vice-Chairman of the Board, were appointed members ex officio. It was understood that if any of the Committee members were unable to attend, except the two ex-officio members, his or her successor, or the alternate member of the Board designated by the government concerned, in accordance with Rule 2 of the Rules of Procedure of the Executive Board, would participate in the work of the Committee. (Third meeting, 31 May 2016)
EB139(4)
Membership of the Léon Bernard Foundation Committee
The Executive Board, in accordance with the Statutes of the Léon Bernard Foundation, appointed Ms Veronika Igorevna Skvortsova (Russian Federation) as a member of the Léon Bernard Foundation Committee for the duration of her term of office on the Executive Board, in addition to the Chairman and Vice-Chairmen of the Board, members ex officio. It was understood that if Ms Svortsova was unable to attend, her successor or the alternate member of the Board designated by the government concerned, in accordance with Rule 2 of the Rules of Procedure of the Executive Board, would participate in the work of the Committee. (Third meeting, 31 May 2016)
EB139(5)
Membership of the United Arab Emirates Health Foundation Committee
The Executive Board, in accordance with the Statutes of the United Arab Emirates Health Foundation, appointed Dr Faiqa Saeed Al-Saleh (Bahrain) as a member of the United Arab Emirates Health Foundation Committee for the duration of her term of office on the Executive Board, in addition to the Chairman of the Board, member ex officio. It was understood that if Dr Al-Saleh was unable to attend, his successor or the alternate member of the Board designated by the government concerned, in accordance with Rule 2 of the Rules of Procedure of the Executive Board, would participate in the work of the Committee. (Third meeting, 31 May 2016)
EB139(6)
Membership of the Sasakawa Health Prize Selection Panel
The Executive Board, in accordance with the Statutes of the Sasakawa Health Prize, appointed Dr Nguyen Kim Tien, (Viet Nam) as a member of the Sasakawa Health Prize Selection Panel for the duration of his term of office on the Executive Board, in addition to the Chairman and a representative appointed by the Founder, members ex officio. It was understood that if Dr Kim Tien was unable to attend, his successor or the alternate member of the Board designated by the government concerned, in accordance with Rule 2 of the Rules of Procedure of the Executive Board, would participate in the work of the Panel. (Third meeting, 31 May 2016)
2
EB139/DIV./2
EB139(7)
Membership of the State of Kuwait Health Promotion Foundation Selection Panel
The Executive Board, in accordance with the Statutes of the State of Kuwait Health Promotion Foundation, appointed Dr Ali Hyasat (Jordan) as a member of the Health Promotion Foundation Selection Panel for the duration of his term of office on the Executive Board, in addition to the Chairman and a representative of the Founder, members ex officio. It was understood that if Dr Hyasat was unable to attend, his successor or the alternate member of the Board designated by the government concerned, in accordance with Rule 2 of the Rules of Procedure of the Executive Board, would participate in the work of the Panel. (Third meeting, 31 May 2016)
EB139(8)
Appointment of representatives of the Executive Board to the Seventieth World Health Assembly
The Executive Board, in accordance with paragraph 1 of resolution EB59.R7, appointed its Chairman, Dr Raymond Busuttil (Malta), and its first three Vice-Chairmen, Dr Thomas Frieden (United States of America), Dr Ramjanam Chaudhary (Nepal) and Ms Zhang Yang (China) to represent the Executive Board at the Seventieth World Health Assembly. It was understood that if any of those members were not available for the Health Assembly, the other Vice-Chairman, Mrs Faeqa Saeed Alsaleh (Bahrain), and the Rapporteur, Mr Omar Sey (Gambia), could be asked to represent the Board. (First meeting, 30 May 2016)
EB139(9)
Process for the election of the Director-General of the World Health Organization: date of the candidates’ forum
The Executive Board, having considered the report on the process for the election of the Director-General of the World Health Organization,1 decided that the candidates’ forum shall be held starting from Tuesday, 1 November 2016 for a duration that will be further decided by the Officers of the Board depending on the number of candidates. (Third meeting, 31 May 2016)
EB139(10)
Place, date and duration of the 140th session of the Executive Board and the twenty-fifth meeting of the Programme Budget and Administration Committee of the Executive Board
The Executive Board decided that its 140th session should be convened on Monday, 23 January 2017, at WHO headquarters, Geneva, and should close no later than Wednesday, 1 February 2017. The Board further decided that the Programme, Budget and Administration Committee of the Executive Board should hold its twenty-fifth meeting from Wednesday, 18 January, to Friday, 20 January 2017, at WHO headquarters, Geneva. (Third meeting, 31 May 2016) 1
Document EB139/11.
3
EB139/DIV./2
EB139(11)
Place, date and duration of the Seventieth World Health Assembly and the twenty-sixth meeting of the Programme, Budget and Administration Committee of the Executive Board
The Executive Board decided that the Seventieth World Health Assembly should be held at the Palais des Nations, Geneva, opening on Monday, 22 May 2017, and should close no later than Wednesday, 31 May 2017. The Board further decided that the Programme, Budget and Administration Committee of the Executive Board should hold its twenty-sixth meeting on Thursday, 18 May and Friday, 19 May 2017, at WHO headquarters, Geneva. (Third meeting, 31 May 2016)
II. LIST OF RESOLUTIONS EB139.R1 Development of a new Health Assembly resolution and action plan for prevention of deafness and hearing loss
=
=
=
4